Skip to main content

What Is Nasal Hyperreactivity?

  • Chapter
  • First Online:
Challenges in Rhinology

Abstract

One definition of nasal hyperreactivity (NHR) is: “the induction of one or more nasal symptoms like rhinorrhea, sneezing/itch, or obstruction upon encounter of environmental stimuli, such as cigarette smoke, temperature/humidity changes, strong odours/fragrances, and other irritants”. NHR may feature in every kind of rhinitis, irrespective of aetiology, including coryza (due to an infection), nonallergenic rhinitis (NAR) or allergic rhinitis (AR). Currently, it appears that chemical (irritant) causes for NHR (smoking, perfumes, cleaning materials) produce the same generalised disturbance of the mucosa lining the nose and upper airways as physical causes, such as changing temperature, exercising, being under stress or in humid conditions. The situation thus appears to resemble that found in conditions producing hyperresponsiveness of the bronchi, such as asthma or COPD (chronic obstructive pulmonary disease), where both chemical and physical triggers produce identical mucosal alterations. Indeed, most cases of untreated airway disease, affecting all portions of the tract (rhinitis and asthma), are said to feature mucosae that are hyperresponsive. In this chapter, NHR is presented.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gerth van Wijk RG, de Graaf-in’t Veld C, Garrelds IM. Nasal hyperreactivity. Rhinology. 1999;37(2):50–5.

    CAS  PubMed  Google Scholar 

  2. Van Gerven L, Steelant B, Hellings PW. Nasal hyperreactivity in rhinitis: a diagnostic and therapeutic challenge. Allergy. 2018;73:1784. https://doi.org/10.1111/all.13453. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  3. Segboer CL, Holland CT, Reinartz SM, et al. Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy. 2013;68:1427–34.

    Article  CAS  PubMed  Google Scholar 

  4. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol. 2001;125:145–54.

    Article  CAS  PubMed  Google Scholar 

  5. Hellings PW, Fokkens WJ, Akdis C, et al. Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today? Allergy. 2013;68:1–7.

    Article  CAS  PubMed  Google Scholar 

  6. Marquez F, Sastre J, Hernandez G, Cenjor C, Sanchez-Hernandez JM, Sanchez J, et al. Nasal hyperreactivity to methacholine measured by acoustic rhinometry in asymptomatic allergic and perennial nonallergic rhinitis. Am J Rhinol. 2000;14:251–6.

    Article  CAS  PubMed  Google Scholar 

  7. Segboer CL, Holland CT, Reinartz SM, Terreehorst I, Gevorgyan A, Hellings PW, van Drunen CM, Fokkens WJ. Nasal hyper-reactivity is a common feature in both allergic and nonallergic rhinitis. Allergy. 2013;68:1427–34.

    Article  CAS  PubMed  Google Scholar 

  8. Cassano M, Cassano P, Ciprandi G. May nasal hyperreactivity be a sequela of recurrent common cold? J Biol Regul Homeost Agents. 2011;25:299–301.

    CAS  PubMed  Google Scholar 

  9. Vaidyanathan S, Williamson P, Clearie K, Morrison A, Lipworth B. Nasal AMP and histamine challenge within and outside the pollen season in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2011;127:173–8.

    Article  CAS  PubMed  Google Scholar 

  10. Van Gerven L, Boeckxstaens G, Hellings P. Up-date on neuroimmune mechanisms involved in allergic and non-allergic rhinitis. Rhinology. 2012;50:227–35.

    Article  PubMed  Google Scholar 

  11. Baraniuk JN, Merck SJ. Neuroregulation of human nasal mucosa. Ann N Y Acad Sci. 2009;1170:604–9.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Baraniuk JN, Castellino S, Lundgren JD, et al. Neuropeptide Y (NPY) in human nasal mucosa. Am J Respir Cell Mol Biol. 1990;3:165–73.

    Article  CAS  PubMed  Google Scholar 

  13. Buckle FG, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol. 1975;55:213–21.

    Article  CAS  PubMed  Google Scholar 

  14. Svensson C, Grönneberg R, Andersson M, Alkner U, Andersson O, Billing B, Gilljam H, Greiff L, Persson CGA. Allergen challenge-induced entry of a2-macroglobulin and tryptase into human nasal and bronchial airways. J Allergy Clin Immunol. 1995;96:239–46.

    Article  CAS  PubMed  Google Scholar 

  15. Svensson C, Andersson M, Persson CGA, et al. Albumin, bradykinins and eosinophil cationic protein on the nasal mucosa surface in hay fever patients during natural allergen exposure. J Allergy Clin Immunol. 1990;85:828–33.

    Article  CAS  PubMed  Google Scholar 

  16. Greiff L, Wollmer P, Svensson C, Andersson M, Persson CGA. Effect of seasonal allergic rhinitis on airway mucosal absorption of chromium-51 labelled EDTA. Thorax. 1993;48:648–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Greiff L, Andersson M, Akerlund A, Wollmer P, Svensson C, Alkner U, Persson CGA. Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold. Thorax. 1994;49:121–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Baraniuk JN. Neuropeptides. Am J Rhinol. 1998;12:9–16.

    Article  CAS  PubMed  Google Scholar 

  19. Jones AS. Autonomic reflexes and non-allergic rhinitis. Allergy. 1997;52(Suppl 36):14–9.

    Article  CAS  PubMed  Google Scholar 

  20. Druce HW, Wright RH, Kossoff D, Kaliner MA. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol. 1985;76:445–52.

    Article  CAS  PubMed  Google Scholar 

  21. Stjarne P, Lundblad L, Lunberg JM, Anggard A. Capsaicin and nicotine sensitive afferent neurons and nasal secretion in healthy human volunteers and in patients with vasomotor rhinitis. Br J Pharmacol. 1989;96:693–701.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. van Megen YJB. Neuroreceptors in nasal allergy, Thesis KU Nijmegen. Meppel: Krips Repro; 1989. p. 137–77.

    Google Scholar 

  23. Fang SY, Shen CL. Neuropeptide innervation and neuroendocrine cells in allergic rhinitis and chronic hypertrophic rhinitis. Clin Exp Allergy. 1998;28:228–32.

    Article  CAS  PubMed  Google Scholar 

  24. Svensson C, Andersson M, Greiff L, Persson GCA. Nasal mucosal endorgan hyperresponsiveness. Am J Rhinol. 1998;12:37–43.

    Article  CAS  PubMed  Google Scholar 

  25. Sanico AM, Philip G, Lai GK, Togias A. Hyperosmolar saline induces reflex nasal secretions, evincing neural hyperresponsiveness in allergic rhinitis. J Appl Physiol (1985). 1999;86:1202–10.

    Article  CAS  Google Scholar 

  26. Koskela H, Di Sciascio MB, Anderson SD, et al. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement. Clin Exp Allergy. 2000;30:1627–36.

    Article  CAS  PubMed  Google Scholar 

  27. Togias AG, Naclerio RM, Proud D, et al. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985;76:1375–81.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Braat JP, Mulder PG, Fokkens WJ, van Wijk RG, Rijntjes E. Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity in nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1748–55.

    Article  CAS  PubMed  Google Scholar 

  29. Kim YH, Jang TY. Diagnostic criteria of nonspecific hyperreactivity using cold dry air provocation with acoustic rhinometry. Otolaryngol Head Neck Surg. 2011;144:91–5.

    Article  PubMed  Google Scholar 

  30. Kowalski ML, Dietrich-Miłobedzki A, Majkowska-Wojciechowska B, Jarzebska M. Nasal reactivity to capsaicin in patients with seasonal allergic rhinitis during and after the pollen season. Allergy. 1999;54:804–10.

    Article  CAS  PubMed  Google Scholar 

  31. Van Gerven L, Boeckxstaens G, Jorissen M, Fokkens W, Hellings PW. Short-time cold dry air exposure: a useful diagnostic tool for nasal hyperresponsiveness. Laryngoscope. 2012;122:2615–20.

    Article  PubMed  Google Scholar 

  32. Gerth van Wijk R, Dieges PH. Nasal hyper-responsiveness to histamine, methacholine and phentolamine in patients with perennial non-allergic rhinitis and in patients with infectious rhinitis. Clin Otolaryngol Allied Sci. 1991;16:133–7.

    Article  CAS  PubMed  Google Scholar 

  33. Holland C, van Drunen C, Denyer J, et al. Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist. Br J Clin Pharmacol. 2013;77:777–88.

    Article  CAS  Google Scholar 

  34. Lluch-Bernal M, Dordal MT, Antón E, Campo P, Colás C, Dávila I, Del Cuvillo Bernal A, Fernández-Parra B, González R, González ML, Matheu V, Montoro J, Panizo C, Rondón C, Sánchez MC, Valero A, Vega F, Velázquez E, Navarro A, SEAIC 2010 Rhinoconjunctivitis Committee. Nasal hyperreactivity: nonspecific nasal provocation tests. Review by the Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol. 2015;25(6):396–407.

    CAS  PubMed  Google Scholar 

  35. Borum P. Nasal methacholine challenge. A test for the measurement of nasal reactivity. J Allergy Clin Immunol. 1979;63(4):253–7.

    Article  CAS  PubMed  Google Scholar 

  36. Naclerio RM, Baroody FM. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol. 1992;90(6 Pt 2):1051–4.

    Article  CAS  PubMed  Google Scholar 

  37. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis. 1993;148(1):91–7.

    Article  CAS  PubMed  Google Scholar 

  38. Polosa R, Pagano C, Prosperini G, Low JL, Dokic D, Church MK, Crimi N. Histamine release upon adenosine 5’monophosphate (AMP) nasal provocation in allergic subjects. Thorax. 1999;54:230–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Assanasen P, Baroody FM, Rouadi P, Naureckas E, Solway J, Naclerio RM. Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1031–7.

    Article  CAS  PubMed  Google Scholar 

  40. Assanasen P, Baroody FM, Abbott DJ, Naureckas E, Solway J, Naclerio RM. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000;106(6):1045–52.

    Article  CAS  PubMed  Google Scholar 

  41. Koskela H, Di Sciascio MB, Anderson SD, Andersson M, Chan HK, Gadalla S, Katelaris C. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement. Clin Exp Allergy. 2000;30:1627–36.

    Article  CAS  PubMed  Google Scholar 

  42. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(Suppl 86):8–160.

    Article  PubMed  Google Scholar 

  43. Jacobs R, Lieberman P, Kent E, Silvey M, Locantore N, Philpot EE. Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment. Allergy Asthma Proc. 2009;30:120–7.

    Article  CAS  PubMed  Google Scholar 

  44. Lundblad L, Sipilä P, Farstad T, Drozdziewicz D. Mometasone furoate nasal spray in the treatment of perennial non-allergic rhinitis: a nordic, multicenter, randomized, double-blind, placebo-controlled study. Acta Otolaryngol. 2001;121:505–9.

    Article  CAS  PubMed  Google Scholar 

  45. Varricchio A, Capasso M, De Lucia A, et al. Intranasal flunisolide treatment in patients with non-allergic rhinitis. Int J Immunopathol Pharmacol. 2011;24:401–9.

    Article  CAS  PubMed  Google Scholar 

  46. Gevorgyan A, Segboer C, Gorissen R, van Drunen CM, Fokkens W. Capsaicin for non-allergic rhinitis. Cochrane Database Syst Rev. 2015;7:CD010591.

    Google Scholar 

  47. Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PGH, Blom HM, Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study. Allergy. 2003;58:754–61.

    Article  PubMed  Google Scholar 

  48. Van Gerven L, Alpizar YA, Wouters MM, et al. Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis. J Allergy Clin Immunol. 2014;133:1332–9.

    Article  PubMed  CAS  Google Scholar 

  49. Gerth Van Wijk R, Terreehorst IT, Mulder PG, Garrelds IM, Blom HM, Popering S. Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite. A placebo-controlled study. Clin Exp Allergy. 2000;30:1792–8.

    Article  CAS  PubMed  Google Scholar 

  50. Gibson RA, Robertson J, Mistry H, et al. A randomised trial evaluating the effects of the TRPV1 antagonist SB705498 on pruritus induced by histamine, and cowhage challenge in healthy volunteers. PLoS One. 2014;9:e100610.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Singh U, Bernstein JA, Haar L, Luther K, Jones WK. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014;28:215–24.

    Article  PubMed  Google Scholar 

  52. Birrell MA, Bonvini SJ, Dubuis E, et al. Tiotropium modulates transient receptor potential V1 (TRPV1) in airway sensory nerves: a beneficial off-target effect? J Allergy Clin Immunol. 2014;133:679–687.e9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Krohn IK, Callebaut I, Alpizar YA, Steelant B, Van Gerven L, Skov PS, et al. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite allergic rhinitis. Allergy. 2018;73:1084. https://doi.org/10.1111/all.13349.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Torun, M.T., Cingi, C., Scadding, G.K. (2021). What Is Nasal Hyperreactivity?. In: Cingi, C., Bayar Muluk, N., Scadding, G.K., Mladina, R. (eds) Challenges in Rhinology. Springer, Cham. https://doi.org/10.1007/978-3-030-50899-9_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-50899-9_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-50898-2

  • Online ISBN: 978-3-030-50899-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics